TrialAntimicrobial resistance and infection control2025

Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial.

Amir Nutman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.